Comparative Antimicrobial Activity and Kill-Curve Investigations of Novel Ketolide Antimicrobial Agents (HMR 3004 and HMR 3647) Tested against Haemophilus influenzae and Moraxella catarrhalis Strains
- 1 June 1998
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 31 (2) , 349-353
- https://doi.org/10.1016/s0732-8893(98)00022-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogensAntimicrobial Agents and Chemotherapy, 1997
- Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004)Antimicrobial Agents and Chemotherapy, 1997
- Antimicrobial activity of RU-66647, a new ketolideDiagnostic Microbiology and Infectious Disease, 1997
- In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004Antimicrobial Agents and Chemotherapy, 1997
- MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococciAntimicrobial Agents and Chemotherapy, 1996
- A survey of β-lactamase-producing Haemophilus influenzae an evaluation of 5750 isolatesDiagnostic Microbiology and Infectious Disease, 1995
- Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United StatesAntimicrobial Agents and Chemotherapy, 1990
- Spectrum of diseases due to Branhamella Catarrhalis in children with particular reference to acute otitis mediaThe American Journal of Medicine, 1990